-
During the early stages of the H1N1 pandemic, the only vaccine available to hospitals was the live attenuated intranasal (LAIV) version, but many shunned LAIV out of an abundance of concern for high-risk patients.
-
Though some other infection prevention duties were shunted aside, IPs and the health care system in general rose to the challenge of the first pandemic in four decades.
-
The Centers for Disease Control and Prevention made "a serious mistake" in holding fast to a recommendation that health care workers wear N95s or comparable respirators during the H1N1 influenza A pandemic, a national pandemic planner says.
-
The death of a nurse from a coinfection with H1N1 influenza A and methicillin-resistant Staphylococcus aureus (MRSA) should have been more thoroughly investigated for a work-related link, according to the California Division of Occupational Safety and Health (Cal-OSHA).
-
Paul Offit, MD, infectious disease chief at the Children's Hospital of Philadelphia, has been front and center in the fight against the growing anti-vaccine movement and he has the hate mail to prove it.
-
HIV clinicians now are advised to consider HIV antiretroviral treatment for patients who have CD4 counts greater than 350 cells/mm3 and perhaps even upon diagnosis.
-
In a study of HIV transmission, 3,408 HIV-1 serodis cordant couples were enrolled at 14 sites in Africa.
-
On Feb. 12, 2010, the Food and Drug Administration (FDA) granted tentative approval for efavirenz cross-scored tablets, 200 mg, manufactured by Strides Arcolab Limited of Bangalore, India. The cross-scored tablet can be broken into two 100 mg or four 50 mg doses to facilitate pediatric dosing.
-
-
A new study shows a continued decline in hospitalizations and emergency department visits among HIV-infected adults in the United States.
